Complications of Soft Tissue Fillers

  • Steven C. Bernstein


Soft tissue augmentation with filling agents (temporary, permanent, and semipermanent) has become one of the most requested interventions in facial aesthetic surgery. Fillers provide an opportunity to quickly correct certain defects that cannot be adequately treated with other modalities. The demand for fillers has created a strong incentive for industry to introduce newer and better products. Consequently, a burgeoning market has developed with multiple fillers possessing many of the attributes of the so-called ideal filler: an agent which is biocompatible, nonantigenic, noninflammatory, nontoxic, stable after injection, nonmigratory, long-lasting, natural looking and feeling, and not too expensive.


Hyaluronic Acid Triamcinolone Acetonide Bovine Collagen Injectable Collagen Acne Scar 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Knapp TE, Kaplan EN, Daniels JR, et al. Injectable collagen for soft tissue augmentation. Plast Reconstr Surg 1997;60:398–405.CrossRefGoogle Scholar
  2. 2.
    Hanke CW. Injectable collagen implants. Arch Dermatol 1983;119:533–534.CrossRefPubMedGoogle Scholar
  3. 3.
    Burgess CP, Goode RC. Injectable collagen. Facial Plastic Surg 1992;8:176–182.CrossRefGoogle Scholar
  4. 4.
    Pollack SV. Silicone, Fibrel, and collagen implantation for facial lines and wrinkles. J Dermatol Surg Oncol 1990;16:957–961.PubMedGoogle Scholar
  5. 5.
    DeLustra F, Smith ST, Sundsmo J, et al. Reaction to injectable collagen in human subjects. J Dermatol Surg Oncol 1998;14(Suppl 1):49.Google Scholar
  6. 6.
    Hochberg MC. Cosmetic surgical procedures and connective tissue disease: the Cleopatra syndrome revisited. Ann Intern Med 1993;118:981–982.PubMedGoogle Scholar
  7. 7.
    Douglas RS, Dansoff I, Cook T, et al. Collagen fillers in facial aesthetic surgery. Facial Plast Surg 2004;2:117–123.CrossRefGoogle Scholar
  8. 8.
    Ellingsworth CR, Delustra F, Brennan SE, et al. The human immune response to reconstructive bovine collagen. J Immunol 1986;136:877–887.PubMedGoogle Scholar
  9. 9.
    Hanke CW, Hingley R, Jolivette DM, et al. Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant. J Am Acad Dermatol 1991;25:319–326.CrossRefPubMedGoogle Scholar
  10. 10.
    Stegman SJ, Chu S, Armstrong R. Adverse reactions to bovine collagen implants; clinical and histologic features. J Dermatol Surg Oncol 1998;14:39–48.Google Scholar
  11. 11.
    Hanke CW. Adverse reactions to bovine collagen. In: Klein A, ed. Augmentation in clinical practice: procedures and techniques. New York: Marcel Dekker; 1998:145.Google Scholar
  12. 12.
    McGrew F, Wilson RS, Havener W, et al. Sudden blindness secondary to injections of common drugs in the head and neck, part 1: clinical experiences. Otolaryngology 1978;86:147–151.Google Scholar
  13. 13.
    Klein AW. Collagen substances. Facial Plast Surg Clin North Am 2001;9:205–218.PubMedGoogle Scholar
  14. 14.
    Moody BR, Sengelmann RD. Self limited adverse reaction to human derived collagen injectible product. Dermatol Surg 2000;26:936–938.CrossRefPubMedGoogle Scholar
  15. 15.
    Cheng JT, Perkins SW, Hamilton AM, et al. Collagen and injectable fillers. Otolaryngol Clin North Am 2002;35:73–85.CrossRefPubMedGoogle Scholar
  16. 16.
    Ascher B, Cerceau M, Baspeyras M, et al. Soft tissue filling with hyaluronic acid. Ann de Chir Plast Esth 2004;49:465–485.CrossRefGoogle Scholar
  17. 17.
    Hoffman C, Schuller-Petrovic, Soyer HP, Kerl H. Adverse reactions after cosmetic lip augmentation with permanent biologically inert implant materials. J Am Acad Dermatol 1999;40:100–102.CrossRefGoogle Scholar
  18. 18.
    Bergeret-Galley B, Latouche X, Illouz Y-G. The value of a new filler material in corrective and cosmetic surgery: Dermalive and Dermadeep. Aesthetic Plast Surg 2001;25:249–255.CrossRefPubMedGoogle Scholar
  19. 19.
    Toy BR, Frank PJ. Outbreak of Mycobacterium abscessus infection after soft tissue augmentation. Dermatol Surg 2003;29:971–973.CrossRefPubMedGoogle Scholar
  20. 20.
    Bergeret-Galley C. Comparison of absorbable soft-tissue fillers. J Aesthetic Surg 2004;24:33–46.CrossRefGoogle Scholar
  21. 21.
    Barr R. Stegman SJ. Delayed skin test reaction to injectable collagen implant (Zyderm). The histopathologic comparative study. J Am Acad Dermatol 1984;10:652–658.CrossRefPubMedGoogle Scholar
  22. 22.
    Lemperle G, Morheim V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg 2003;27:354–366.CrossRefPubMedGoogle Scholar
  23. 23.
    Lowe NJ, Maxwell CA, Lowe P, et al. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol 2001;45:930–933.CrossRefPubMedGoogle Scholar
  24. 24.
    Cotran RS, Kumar V, Robins SL. Pathologic basis of disease. 5th ed. Philadelphia: Saunders; 1994.Google Scholar
  25. 25.
    Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with Artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg 2003;29:573–587.CrossRefPubMedGoogle Scholar
  26. 26.
    Kim KJ, Lee HW, Lee MW, et al. Artecoll granulomas: a rare adverse reaction induced by microimplant in the treatment of neck wrinkles. Dermatol Surg 2004;30:545–547.CrossRefPubMedGoogle Scholar
  27. 27.
    Silva MT, Curi AL. Blindness and total opthalmoplagia after aesthetic polymethyl methacrylate injection. Arq Neuropsiquiatr 2004;62:873–874.PubMedGoogle Scholar
  28. 28.
    Senet P, Backclez H, Ollivaud L. Minocycline for the treatment of cutaneous silicone granulomas. Br J Dermatol 1999;140:985–987.CrossRefPubMedGoogle Scholar
  29. 29.
    Sidwell RV, Dhillon AP, Butler PE, et al. Localized granulamotous reaction to a semi-permanent hyaluronic acid and acrylic hydrogel cosmetic filler. Clin Exp Dermatology 2004;29:630–637.CrossRefGoogle Scholar
  30. 30.
    De Cassia Novaes W, Berg A. Experiences with a new nonbiodegradable hydrogel (Aquamid): a pilot study. Aesthetic Plast Surg 2003;27:376–380.CrossRefPubMedGoogle Scholar
  31. 31.
    Amin SP, Marmur ES, Goldberg DJ, et al. Complications from injectable polyacrylamide, a new biodegradable soft tissue filler. Dermatol Surg 2004;30:1507–1509.CrossRefPubMedGoogle Scholar
  32. 32.
    Valantin MA, Aubron-Olivier C, Ghosn J, et al. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open label study VEGA. AIDS 2003;17:2471–2477.CrossRefPubMedGoogle Scholar
  33. 33.
    Burgess CM, Quiroga RA. Assessment of the safety and efficacy of poly-L-Lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol 2005;52:232–239.Google Scholar
  34. 34.
    Flaherty P. Radiance. Facial Plast Surg 2004;20:165–169.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Steven C. Bernstein
    • 1
  1. 1.Department of MedicineUniversity of MontrealMontrealCanada

Personalised recommendations